All for Joomla All for Webmasters

Emergence of institutional antithrombotic protocols for coronavirus 2019

Rate this item
(0 votes)

Abstract:

Abstract The coronavirus infection (COVID-19), first identified in December 2019 in Wuhan, China, is a major public health crisis with new infections increasing exponentially worldwide. COVID-19 is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and has contributed to significant morbidity and mortality, including the development of coagulopathy. Similar thrombotic and thromboembolic events have occurred during other viral outbreaks, including severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome (MERS-CoV), and influenza A H1N1.

Additional Info

Read 147 times

Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service

No Internet Connection